Literature DB >> 26077262

Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faecium.

Emmanuelle Sacco1, Mélanie Cortes1, Nathalie Josseaume1, Christiane Bouchier2, Vincent Dubée1, Jean-Emmanuel Hugonnet1, Jean-Luc Mainardi3, Louis B Rice4, Michel Arthur5.   

Abstract

Bypass of the d,d-transpeptidase activity of penicillin-binding proteins by an l,d-transpeptidase (Ldtfm) results in resistance to ampicillin and glycopeptides in Enterococcus faecium M9, a mutant obtained by nine consecutive selection steps. Resistance requires activation of a cryptic locus for production of the essential tetrapeptide-containing substrate of Ldtfm and impaired activity of protein phosphatase StpA. Here, whole-genome sequencing revealed a high mutation rate for the entire selection procedure (79 mutations in 900 generations). Acquisition of a mutation in the mismatch repair gene mutL had little impact on the frequency of rifampin-resistant mutants although the mutation spectrum of M9 was typical of impaired MutL with high transversion to transition (40/11) and substitution to deletion (51/28) ratios. M9 did not mainly accumulate neutral mutations since base substitutions occurred more frequently in coding sequences than expected (χ(2) = 5.0; P < 0.05) and silent mutations were underrepresented (χ(2) = 5.72; P < 0.02). None of the mutations directly affected recognition of the tetrapeptide substrate of Ldtfm by peptidoglycan synthesis enzymes. Instead, mutations appear to remodel regulatory circuits involving two-component regulatory systems and sugar metabolism. The high number of mutations required for activation of the l,d-transpeptidase pathway may strongly limit emergence of cross-resistance to ampicillin and glycopeptides by this mechanism.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077262      PMCID: PMC4538475          DOI: 10.1128/AAC.00634-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Novel mechanism of resistance to glycopeptide antibiotics in Enterococcus faecium.

Authors:  Julie Cremniter; Jean-Luc Mainardi; Nathalie Josseaume; Jean-Charles Quincampoix; Lionel Dubost; Jean-Emmanuel Hugonnet; Arul Marie; Laurent Gutmann; Louis B Rice; Michel Arthur
Journal:  J Biol Chem       Date:  2006-08-29       Impact factor: 5.157

2.  Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci.

Authors:  M Arthur; F Depardieu; L Cabanié; P Reynolds; P Courvalin
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

3.  Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.

Authors:  Pradeep Kumar; Kriti Arora; John R Lloyd; Ill Y Lee; Vinod Nair; Elizabeth Fischer; Helena I M Boshoff; Clifton E Barry
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501

4.  Role of class A penicillin-binding proteins in PBP5-mediated beta-lactam resistance in Enterococcus faecalis.

Authors:  Ana Arbeloa; Heidi Segal; Jean-Emmanuel Hugonnet; Nathalie Josseaume; Lionnel Dubost; Jean-Paul Brouard; Laurent Gutmann; Dominique Mengin-Lecreulx; Michel Arthur
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

5.  Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium.

Authors:  Jean-Luc Mainardi; Véronique Morel; Martine Fourgeaud; Julie Cremniter; Didier Blanot; Raymond Legrand; Claude Frehel; Michel Arthur; Jean Van Heijenoort; Laurent Gutmann
Journal:  J Biol Chem       Date:  2002-06-19       Impact factor: 5.157

6.  Translesion DNA Synthesis.

Authors:  Alexandra Vaisman; John P McDonald; Roger Woodgate
Journal:  EcoSal Plus       Date:  2012-11

7.  Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.

Authors:  Daria Soroka; Vincent Dubée; Olivia Soulier-Escrihuela; Guillaume Cuinet; Jean-Emmanuel Hugonnet; Laurent Gutmann; Jean-Luc Mainardi; Michel Arthur
Journal:  J Antimicrob Chemother       Date:  2013-10-16       Impact factor: 5.790

Review 8.  The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.

Authors:  Eric Sauvage; Frédéric Kerff; Mohammed Terrak; Juan A Ayala; Paulette Charlier
Journal:  FEMS Microbiol Rev       Date:  2008-02-11       Impact factor: 16.408

9.  The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis.

Authors:  Yannick Comenge; Richard Quintiliani; Ling Li; Lionnel Dubost; Jean-Paul Brouard; Jean-Emmanuel Hugonnet; Michel Arthur
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

10.  Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  3 in total

1.  L,D-Transpeptidase Specific Probe Reveals Spatial Activity of Peptidoglycan Cross-Linking.

Authors:  Sean E Pidgeon; Alexis J Apostolos; Julia M Nelson; Moagi Shaku; Binayak Rimal; M Nurul Islam; Dean C Crick; Sung Joon Kim; Martin S Pavelka; Bavesh D Kana; Marcos M Pires
Journal:  ACS Chem Biol       Date:  2019-09-16       Impact factor: 5.100

Review 2.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29

3.  Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq).

Authors:  Romain Guérillot; Lucy Li; Sarah Baines; Brian Howden; Mark B Schultz; Torsten Seemann; Ian Monk; Sacha J Pidot; Wei Gao; Stefano Giulieri; Anders Gonçalves da Silva; Anthony D'Agata; Takehiro Tomita; Anton Y Peleg; Timothy P Stinear; Benjamin P Howden
Journal:  Genome Med       Date:  2018-08-31       Impact factor: 11.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.